Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares traded up 11.1% during trading on Tuesday . The company traded as high as GBX 3.68 and last traded at GBX 3.50. 20,624,805 shares were traded during mid-day trading, an increase of 1,413% from the average session volume of 1,363,058 shares. The stock had previously closed at GBX 3.15.
Cizzle Biotechnology Stock Performance
The stock’s fifty day moving average price is GBX 2.71 and its 200-day moving average price is GBX 2.01. The company has a market capitalization of £14.87 million, a P/E ratio of -20.59 and a beta of 0.07.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported GBX (0.17) EPS for the quarter.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- 5 High-Yield Stocks With Analyst Support and Room to Run
- AST SpaceMobile Announces Launch Date for Its Next 3 BlueBird Satellites
- Is Lennar Finally Turning the Corner After Its Housing Slump?
- AI Memory Demand Has Turned These 5 S&P 500 Stocks Into Market Leaders
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
